Gujarat Meditech (Delisted) financials and balance sheet

BSE: 524754Healthcare Equipment & Supplies

Last traded ₹4.20 on 6 Jan 2020

Delisted on 13 Jul 2022.

9 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Gujarat Meditech annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹0.72 Cr, year to Mar 2018A loss in 2 of the 6 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2018

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.7
  2. Other income0.0

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2016.Gujarat Meditech quarterly results

₹ croreMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue from operations0.220.280.300.320.120.07–0.440.72
–––––––––
Materials and goods bought–––0.270.090.04––0.72
Depreciation and amortisation0.010.010.010.000.000.00–––
Other income––––––––0.03
Profit before tax0.020.030.030.00−0.020.00–0.00–
Tax0.010.000.000.00–––––
Net profit0.010.030.030.00−0.020.00–––
Net margin4.5%8.9%10.4%−1.3%−12.3%1.4%–––
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2010, Mar 2011, Mar 2012, Mar 2013, Mar 2014 and Mar 2015: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.

Ratios

Standalone, years to March.

RatioMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue growth27.0%5.3%6.7%−61.5%−43.4%––64.2%
Net profit growth150.0%24.0%––––––

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2018.

Measure5 years3 years
Revenue growth, yearly rate17.8%118.4%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Effective tax ratePublished threshold 17.16 per cent47.6213.796.06––––––
A threshold marked as ours has no published figure; it is the line we read the check against.